Mainz, Germany

Dieter Kraemer


Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 330(Granted Patents)


Company Filing History:


Years Active: 1977-2001

Loading Chart...
14 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Dieter Kraemer**

Introduction

Dieter Kraemer, a distinguished inventor based in Mainz, Germany, has made significant strides in the field of biochemistry. With an impressive portfolio of 14 patents, his work primarily focuses on the synthesis of beta-lactam antibiotics, showcasing his commitment to enhancing pharmaceutical production through innovative methodologies.

Latest Patents

Among his latest patents is a groundbreaking method for the synthesis of beta-lactam antibiotics utilizing immobilized penicillin amidase. This inventive process involves the reaction of an amino-beta-lactam component with a corresponding amino-group-containing acylating side-chain component. The distinctive feature of this patent lies in its application of immobilized penicillin amidase, which is covalently attached to support particles. Upon lowering the pH with an acid, such as sulfuric acid, the resulting beta-lactam antibiotic product is solubilized, allowing for the separation of the antibiotic. Notably, the immobilized penicillin amidase can be reactivated for further use through treatment with a neutral pH buffer. The antibiotics produced through this innovative method include well-known drugs like ampicillin, amoxicillin, cephalexin, cefaclor, and cefadroxil. Furthermore, he has developed high surface area support systems for the immobilization of various substances containing nucleophilic groups, enhancing applications in pollutant removal and organic synthesis.

Career Highlights

Dieter Kraemer's career is marked by his tenure at prominent companies including Rohm GmbH and Siol, as well as Werner Roehm GmbH Chemische Fabrik. His innovative contributions during this period have played a crucial role in advancing the synthesis processes in these organizations, cementing his reputation as a valuable asset in the chemical and pharmaceutical industries.

Collaborations

Throughout his professional journey, Kraemer has collaborated with notable colleagues such as Hermann Plainer and Klaus Lehmann. Together, they have fostered a collaborative environment that has propelled research and development in antibiotic synthesis, thereby impacting the field significantly.

Conclusion

Dieter Kraemer exemplifies the spirit of innovation in the realm of biochemistry and pharmaceuticals. With his numerous patents and collaborative efforts, he continues to influence the development of vital antibiotics and enhance methodologies that would benefit future research and pharmaceutical applications. His remarkable contributions stand as a testament to the importance of innovation in addressing health challenges globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…